nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—SLC22A2—Vinblastine—lung cancer	0.193	0.28	CbGbCtD
Oxprenolol—SLC22A2—Cisplatin—lung cancer	0.177	0.257	CbGbCtD
Oxprenolol—CYP2D6—Gefitinib—lung cancer	0.102	0.148	CbGbCtD
Oxprenolol—CYP2D6—Vinorelbine—lung cancer	0.0785	0.114	CbGbCtD
Oxprenolol—CYP2D6—Erlotinib—lung cancer	0.0603	0.0875	CbGbCtD
Oxprenolol—CYP2D6—Vinblastine—lung cancer	0.0484	0.0703	CbGbCtD
Oxprenolol—CYP2D6—Doxorubicin—lung cancer	0.0297	0.0432	CbGbCtD
Oxprenolol—Diplopia—Crizotinib—lung cancer	0.00436	0.0223	CcSEcCtD
Oxprenolol—Bradycardia—Crizotinib—lung cancer	0.00307	0.0157	CcSEcCtD
Oxprenolol—Bronchospasm—Teniposide—lung cancer	0.00275	0.014	CcSEcCtD
Oxprenolol—Cardiac failure—Vinorelbine—lung cancer	0.0021	0.0107	CcSEcCtD
Oxprenolol—Arthralgia—Pemetrexed—lung cancer	0.00205	0.0104	CcSEcCtD
Oxprenolol—Thrombocytopenia—Pemetrexed—lung cancer	0.00192	0.0098	CcSEcCtD
Oxprenolol—Thrombocytopenia—Gefitinib—lung cancer	0.00191	0.00974	CcSEcCtD
Oxprenolol—Dyspepsia—Crizotinib—lung cancer	0.00189	0.00964	CcSEcCtD
Oxprenolol—Fatigue—Crizotinib—lung cancer	0.00185	0.00944	CcSEcCtD
Oxprenolol—Hypotension—Gefitinib—lung cancer	0.00182	0.00929	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Pemetrexed—lung cancer	0.00179	0.00912	CcSEcCtD
Oxprenolol—Bronchospasm—Vinorelbine—lung cancer	0.00174	0.00889	CcSEcCtD
Oxprenolol—Dyspepsia—Pemetrexed—lung cancer	0.00173	0.00881	CcSEcCtD
Oxprenolol—Fatigue—Pemetrexed—lung cancer	0.00169	0.00863	CcSEcCtD
Oxprenolol—Cardiac failure—Gemcitabine—lung cancer	0.00169	0.00861	CcSEcCtD
Oxprenolol—Fatigue—Gefitinib—lung cancer	0.00168	0.00857	CcSEcCtD
Oxprenolol—Thrombocytopenia—Teniposide—lung cancer	0.00155	0.00794	CcSEcCtD
Oxprenolol—Abdominal pain—Pemetrexed—lung cancer	0.00155	0.00791	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Irinotecan—lung cancer	0.00154	0.00788	CcSEcCtD
Oxprenolol—Abdominal pain—Gefitinib—lung cancer	0.00154	0.00786	CcSEcCtD
Oxprenolol—Asthenia—Crizotinib—lung cancer	0.00154	0.00786	CcSEcCtD
Oxprenolol—Hyperhidrosis—Teniposide—lung cancer	0.00154	0.00784	CcSEcCtD
Oxprenolol—Hypotension—Teniposide—lung cancer	0.00148	0.00757	CcSEcCtD
Oxprenolol—Diarrhoea—Crizotinib—lung cancer	0.00147	0.00749	CcSEcCtD
Oxprenolol—Hypersensitivity—Pemetrexed—lung cancer	0.00144	0.00737	CcSEcCtD
Oxprenolol—Cardiac failure—Etoposide—lung cancer	0.00144	0.00735	CcSEcCtD
Oxprenolol—Hypersensitivity—Gefitinib—lung cancer	0.00144	0.00733	CcSEcCtD
Oxprenolol—Sweating increased—Irinotecan—lung cancer	0.00142	0.00726	CcSEcCtD
Oxprenolol—Dizziness—Crizotinib—lung cancer	0.00142	0.00724	CcSEcCtD
Oxprenolol—Hypoglycaemia—Paclitaxel—lung cancer	0.00141	0.00721	CcSEcCtD
Oxprenolol—Cardiac failure—Paclitaxel—lung cancer	0.00141	0.00721	CcSEcCtD
Oxprenolol—Asthenia—Pemetrexed—lung cancer	0.00141	0.00718	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Cisplatin—lung cancer	0.0014	0.00715	CcSEcCtD
Oxprenolol—Bronchospasm—Gemcitabine—lung cancer	0.0014	0.00714	CcSEcCtD
Oxprenolol—Asthenia—Gefitinib—lung cancer	0.0014	0.00713	CcSEcCtD
Oxprenolol—Pruritus—Pemetrexed—lung cancer	0.00139	0.00708	CcSEcCtD
Oxprenolol—Pruritus—Gefitinib—lung cancer	0.00138	0.00704	CcSEcCtD
Oxprenolol—Diarrhoea—Pemetrexed—lung cancer	0.00134	0.00685	CcSEcCtD
Oxprenolol—Diarrhoea—Gefitinib—lung cancer	0.00133	0.0068	CcSEcCtD
Oxprenolol—Dizziness—Pemetrexed—lung cancer	0.0013	0.00662	CcSEcCtD
Oxprenolol—Sweating increased—Cisplatin—lung cancer	0.00129	0.00659	CcSEcCtD
Oxprenolol—Nausea—Crizotinib—lung cancer	0.00127	0.0065	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Paclitaxel—lung cancer	0.00126	0.00642	CcSEcCtD
Oxprenolol—Abdominal pain—Teniposide—lung cancer	0.00126	0.00641	CcSEcCtD
Oxprenolol—Arthralgia—Topotecan—lung cancer	0.00123	0.00627	CcSEcCtD
Oxprenolol—Arthralgia—Erlotinib—lung cancer	0.00121	0.0062	CcSEcCtD
Oxprenolol—Cardiac failure—Docetaxel—lung cancer	0.0012	0.00611	CcSEcCtD
Oxprenolol—Bronchospasm—Etoposide—lung cancer	0.00119	0.0061	CcSEcCtD
Oxprenolol—Bradycardia—Irinotecan—lung cancer	0.00119	0.00607	CcSEcCtD
Oxprenolol—Thrombocytopenia—Vinblastine—lung cancer	0.00119	0.00606	CcSEcCtD
Oxprenolol—Sweating increased—Etoposide—lung cancer	0.00118	0.00604	CcSEcCtD
Oxprenolol—Hypersensitivity—Teniposide—lung cancer	0.00117	0.00597	CcSEcCtD
Oxprenolol—Nausea—Pemetrexed—lung cancer	0.00116	0.00594	CcSEcCtD
Oxprenolol—Sweating increased—Paclitaxel—lung cancer	0.00116	0.00592	CcSEcCtD
Oxprenolol—Nausea—Gefitinib—lung cancer	0.00116	0.00591	CcSEcCtD
Oxprenolol—Thrombocytopenia—Topotecan—lung cancer	0.00115	0.00588	CcSEcCtD
Oxprenolol—Thrombocytopenia—Erlotinib—lung cancer	0.00114	0.00582	CcSEcCtD
Oxprenolol—Asthenia—Teniposide—lung cancer	0.00114	0.00582	CcSEcCtD
Oxprenolol—Hyperhidrosis—Topotecan—lung cancer	0.00114	0.00581	CcSEcCtD
Oxprenolol—Pruritus—Teniposide—lung cancer	0.00112	0.00574	CcSEcCtD
Oxprenolol—Palpitations—Vinorelbine—lung cancer	0.00109	0.00557	CcSEcCtD
Oxprenolol—Diarrhoea—Teniposide—lung cancer	0.00109	0.00555	CcSEcCtD
Oxprenolol—Bradycardia—Cisplatin—lung cancer	0.00108	0.00552	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Topotecan—lung cancer	0.00107	0.00547	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Docetaxel—lung cancer	0.00107	0.00545	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Erlotinib—lung cancer	0.00106	0.00542	CcSEcCtD
Oxprenolol—Insomnia—Erlotinib—lung cancer	0.00105	0.00538	CcSEcCtD
Oxprenolol—Arthralgia—Vinorelbine—lung cancer	0.00105	0.00536	CcSEcCtD
Oxprenolol—Dyspepsia—Topotecan—lung cancer	0.00104	0.00529	CcSEcCtD
Oxprenolol—Dyspepsia—Erlotinib—lung cancer	0.00103	0.00523	CcSEcCtD
Oxprenolol—Fatigue—Topotecan—lung cancer	0.00101	0.00518	CcSEcCtD
Oxprenolol—Fatigue—Erlotinib—lung cancer	0.001	0.00513	CcSEcCtD
Oxprenolol—Headache—Teniposide—lung cancer	0.000995	0.00508	CcSEcCtD
Oxprenolol—Bronchospasm—Docetaxel—lung cancer	0.000993	0.00507	CcSEcCtD
Oxprenolol—Abnormal dreams—Doxorubicin—lung cancer	0.000992	0.00507	CcSEcCtD
Oxprenolol—Thrombocytopenia—Vinorelbine—lung cancer	0.000986	0.00503	CcSEcCtD
Oxprenolol—Bradycardia—Paclitaxel—lung cancer	0.00097	0.00495	CcSEcCtD
Oxprenolol—Abdominal pain—Vinblastine—lung cancer	0.000958	0.00489	CcSEcCtD
Oxprenolol—Nausea—Teniposide—lung cancer	0.000943	0.00482	CcSEcCtD
Oxprenolol—Hypotension—Vinorelbine—lung cancer	0.000941	0.0048	CcSEcCtD
Oxprenolol—Abdominal pain—Topotecan—lung cancer	0.00093	0.00475	CcSEcCtD
Oxprenolol—Abdominal pain—Erlotinib—lung cancer	0.000921	0.0047	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000917	0.00468	CcSEcCtD
Oxprenolol—Hypersensitivity—Vinblastine—lung cancer	0.000893	0.00456	CcSEcCtD
Oxprenolol—Asthenia—Vinblastine—lung cancer	0.000869	0.00444	CcSEcCtD
Oxprenolol—Fatigue—Vinorelbine—lung cancer	0.000868	0.00443	CcSEcCtD
Oxprenolol—Hypersensitivity—Topotecan—lung cancer	0.000867	0.00443	CcSEcCtD
Oxprenolol—Asthenia—Topotecan—lung cancer	0.000844	0.00431	CcSEcCtD
Oxprenolol—Arthralgia—Gemcitabine—lung cancer	0.000844	0.00431	CcSEcCtD
Oxprenolol—Asthenia—Erlotinib—lung cancer	0.000836	0.00427	CcSEcCtD
Oxprenolol—Pruritus—Topotecan—lung cancer	0.000833	0.00425	CcSEcCtD
Oxprenolol—Diarrhoea—Vinblastine—lung cancer	0.000829	0.00423	CcSEcCtD
Oxprenolol—Pruritus—Erlotinib—lung cancer	0.000824	0.00421	CcSEcCtD
Oxprenolol—Thrombocytopenia—Irinotecan—lung cancer	0.000813	0.00415	CcSEcCtD
Oxprenolol—Diarrhoea—Topotecan—lung cancer	0.000805	0.00411	CcSEcCtD
Oxprenolol—Hyperhidrosis—Irinotecan—lung cancer	0.000803	0.0041	CcSEcCtD
Oxprenolol—Dizziness—Vinblastine—lung cancer	0.000801	0.00409	CcSEcCtD
Oxprenolol—Diarrhoea—Erlotinib—lung cancer	0.000797	0.00407	CcSEcCtD
Oxprenolol—Abdominal pain—Vinorelbine—lung cancer	0.000796	0.00406	CcSEcCtD
Oxprenolol—Thrombocytopenia—Gemcitabine—lung cancer	0.000792	0.00404	CcSEcCtD
Oxprenolol—Hyperhidrosis—Gemcitabine—lung cancer	0.000782	0.00399	CcSEcCtD
Oxprenolol—Dizziness—Topotecan—lung cancer	0.000778	0.00397	CcSEcCtD
Oxprenolol—Hypotension—Irinotecan—lung cancer	0.000776	0.00396	CcSEcCtD
Oxprenolol—Dizziness—Erlotinib—lung cancer	0.00077	0.00393	CcSEcCtD
Oxprenolol—Headache—Vinblastine—lung cancer	0.000759	0.00387	CcSEcCtD
Oxprenolol—Hypotension—Gemcitabine—lung cancer	0.000756	0.00386	CcSEcCtD
Oxprenolol—Insomnia—Irinotecan—lung cancer	0.000751	0.00383	CcSEcCtD
Oxprenolol—Cardiac failure—Doxorubicin—lung cancer	0.000747	0.00381	CcSEcCtD
Oxprenolol—Hypoglycaemia—Doxorubicin—lung cancer	0.000747	0.00381	CcSEcCtD
Oxprenolol—Hypersensitivity—Vinorelbine—lung cancer	0.000742	0.00379	CcSEcCtD
Oxprenolol—Thrombocytopenia—Cisplatin—lung cancer	0.000738	0.00377	CcSEcCtD
Oxprenolol—Headache—Topotecan—lung cancer	0.000737	0.00376	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000737	0.00376	CcSEcCtD
Oxprenolol—Palpitations—Paclitaxel—lung cancer	0.000733	0.00374	CcSEcCtD
Oxprenolol—Insomnia—Gemcitabine—lung cancer	0.000732	0.00373	CcSEcCtD
Oxprenolol—Dyspepsia—Irinotecan—lung cancer	0.000731	0.00373	CcSEcCtD
Oxprenolol—Headache—Erlotinib—lung cancer	0.00073	0.00372	CcSEcCtD
Oxprenolol—Diplopia—Doxorubicin—lung cancer	0.000729	0.00372	CcSEcCtD
Oxprenolol—Hyperhidrosis—Cisplatin—lung cancer	0.000729	0.00372	CcSEcCtD
Oxprenolol—Asthenia—Vinorelbine—lung cancer	0.000722	0.00369	CcSEcCtD
Oxprenolol—Nausea—Vinblastine—lung cancer	0.00072	0.00367	CcSEcCtD
Oxprenolol—Fatigue—Irinotecan—lung cancer	0.000716	0.00365	CcSEcCtD
Oxprenolol—Pruritus—Vinorelbine—lung cancer	0.000712	0.00364	CcSEcCtD
Oxprenolol—Arthralgia—Paclitaxel—lung cancer	0.000706	0.00361	CcSEcCtD
Oxprenolol—Hypotension—Cisplatin—lung cancer	0.000704	0.0036	CcSEcCtD
Oxprenolol—Nausea—Topotecan—lung cancer	0.000699	0.00357	CcSEcCtD
Oxprenolol—Fatigue—Gemcitabine—lung cancer	0.000697	0.00356	CcSEcCtD
Oxprenolol—Nausea—Erlotinib—lung cancer	0.000692	0.00353	CcSEcCtD
Oxprenolol—Diarrhoea—Vinorelbine—lung cancer	0.000689	0.00352	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000687	0.00351	CcSEcCtD
Oxprenolol—Thrombocytopenia—Etoposide—lung cancer	0.000676	0.00345	CcSEcCtD
Oxprenolol—Hyperhidrosis—Etoposide—lung cancer	0.000668	0.00341	CcSEcCtD
Oxprenolol—Dizziness—Vinorelbine—lung cancer	0.000666	0.0034	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Doxorubicin—lung cancer	0.000666	0.0034	CcSEcCtD
Oxprenolol—Thrombocytopenia—Paclitaxel—lung cancer	0.000663	0.00338	CcSEcCtD
Oxprenolol—Abdominal pain—Irinotecan—lung cancer	0.000656	0.00335	CcSEcCtD
Oxprenolol—Hyperhidrosis—Paclitaxel—lung cancer	0.000655	0.00334	CcSEcCtD
Oxprenolol—Hypotension—Etoposide—lung cancer	0.000645	0.00329	CcSEcCtD
Oxprenolol—Hypotension—Paclitaxel—lung cancer	0.000633	0.00323	CcSEcCtD
Oxprenolol—Headache—Vinorelbine—lung cancer	0.000631	0.00322	CcSEcCtD
Oxprenolol—Palpitations—Docetaxel—lung cancer	0.000622	0.00317	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000617	0.00315	CcSEcCtD
Oxprenolol—Insomnia—Paclitaxel—lung cancer	0.000613	0.00313	CcSEcCtD
Oxprenolol—Hypersensitivity—Irinotecan—lung cancer	0.000612	0.00312	CcSEcCtD
Oxprenolol—Arthralgia—Docetaxel—lung cancer	0.000599	0.00306	CcSEcCtD
Oxprenolol—Nausea—Vinorelbine—lung cancer	0.000598	0.00305	CcSEcCtD
Oxprenolol—Dyspepsia—Paclitaxel—lung cancer	0.000596	0.00304	CcSEcCtD
Oxprenolol—Asthenia—Irinotecan—lung cancer	0.000596	0.00304	CcSEcCtD
Oxprenolol—Fatigue—Etoposide—lung cancer	0.000595	0.00304	CcSEcCtD
Oxprenolol—Fatigue—Paclitaxel—lung cancer	0.000584	0.00298	CcSEcCtD
Oxprenolol—Asthenia—Gemcitabine—lung cancer	0.00058	0.00296	CcSEcCtD
Oxprenolol—Pruritus—Gemcitabine—lung cancer	0.000572	0.00292	CcSEcCtD
Oxprenolol—Diarrhoea—Irinotecan—lung cancer	0.000568	0.0029	CcSEcCtD
Oxprenolol—Thrombocytopenia—Docetaxel—lung cancer	0.000562	0.00287	CcSEcCtD
Oxprenolol—Hypersensitivity—Cisplatin—lung cancer	0.000555	0.00284	CcSEcCtD
Oxprenolol—Diarrhoea—Gemcitabine—lung cancer	0.000553	0.00283	CcSEcCtD
Oxprenolol—Dizziness—Irinotecan—lung cancer	0.000549	0.0028	CcSEcCtD
Oxprenolol—Abdominal pain—Etoposide—lung cancer	0.000546	0.00279	CcSEcCtD
Oxprenolol—Asthenia—Cisplatin—lung cancer	0.000541	0.00276	CcSEcCtD
Oxprenolol—Hypotension—Docetaxel—lung cancer	0.000536	0.00274	CcSEcCtD
Oxprenolol—Abdominal pain—Paclitaxel—lung cancer	0.000535	0.00273	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000523	0.00267	CcSEcCtD
Oxprenolol—Headache—Irinotecan—lung cancer	0.00052	0.00266	CcSEcCtD
Oxprenolol—Insomnia—Docetaxel—lung cancer	0.000519	0.00265	CcSEcCtD
Oxprenolol—Diarrhoea—Cisplatin—lung cancer	0.000516	0.00263	CcSEcCtD
Oxprenolol—Bradycardia—Doxorubicin—lung cancer	0.000513	0.00262	CcSEcCtD
Oxprenolol—Hypersensitivity—Etoposide—lung cancer	0.000509	0.0026	CcSEcCtD
Oxprenolol—Headache—Gemcitabine—lung cancer	0.000507	0.00259	CcSEcCtD
Oxprenolol—Dyspepsia—Docetaxel—lung cancer	0.000505	0.00258	CcSEcCtD
Oxprenolol—Hypersensitivity—Paclitaxel—lung cancer	0.000499	0.00255	CcSEcCtD
Oxprenolol—Asthenia—Etoposide—lung cancer	0.000496	0.00253	CcSEcCtD
Oxprenolol—Fatigue—Docetaxel—lung cancer	0.000495	0.00253	CcSEcCtD
Oxprenolol—Nausea—Irinotecan—lung cancer	0.000493	0.00252	CcSEcCtD
Oxprenolol—Pruritus—Etoposide—lung cancer	0.000489	0.00249	CcSEcCtD
Oxprenolol—Asthenia—Paclitaxel—lung cancer	0.000486	0.00248	CcSEcCtD
Oxprenolol—Nausea—Gemcitabine—lung cancer	0.00048	0.00245	CcSEcCtD
Oxprenolol—Pruritus—Paclitaxel—lung cancer	0.000479	0.00245	CcSEcCtD
Oxprenolol—Diarrhoea—Etoposide—lung cancer	0.000473	0.00241	CcSEcCtD
Oxprenolol—Diarrhoea—Paclitaxel—lung cancer	0.000463	0.00237	CcSEcCtD
Oxprenolol—Dizziness—Etoposide—lung cancer	0.000457	0.00233	CcSEcCtD
Oxprenolol—Abdominal pain—Docetaxel—lung cancer	0.000454	0.00232	CcSEcCtD
Oxprenolol—Dizziness—Paclitaxel—lung cancer	0.000448	0.00229	CcSEcCtD
Oxprenolol—Nausea—Cisplatin—lung cancer	0.000448	0.00229	CcSEcCtD
Oxprenolol—Headache—Etoposide—lung cancer	0.000433	0.00221	CcSEcCtD
Oxprenolol—Arthralgia—Methotrexate—lung cancer	0.000432	0.0022	CcSEcCtD
Oxprenolol—Headache—Paclitaxel—lung cancer	0.000424	0.00217	CcSEcCtD
Oxprenolol—Hypersensitivity—Docetaxel—lung cancer	0.000423	0.00216	CcSEcCtD
Oxprenolol—Asthenia—Docetaxel—lung cancer	0.000412	0.0021	CcSEcCtD
Oxprenolol—Nausea—Etoposide—lung cancer	0.00041	0.00209	CcSEcCtD
Oxprenolol—Pruritus—Docetaxel—lung cancer	0.000406	0.00207	CcSEcCtD
Oxprenolol—Thrombocytopenia—Methotrexate—lung cancer	0.000405	0.00207	CcSEcCtD
Oxprenolol—Nausea—Paclitaxel—lung cancer	0.000402	0.00205	CcSEcCtD
Oxprenolol—Hyperhidrosis—Methotrexate—lung cancer	0.0004	0.00204	CcSEcCtD
Oxprenolol—Atenolol—ABCB1—lung cancer	0.000398	0.261	CrCbGaD
Oxprenolol—Diarrhoea—Docetaxel—lung cancer	0.000393	0.002	CcSEcCtD
Oxprenolol—Palpitations—Doxorubicin—lung cancer	0.000388	0.00198	CcSEcCtD
Oxprenolol—Hypotension—Methotrexate—lung cancer	0.000387	0.00197	CcSEcCtD
Oxprenolol—Dizziness—Docetaxel—lung cancer	0.00038	0.00194	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000377	0.00192	CcSEcCtD
Oxprenolol—Insomnia—Methotrexate—lung cancer	0.000374	0.00191	CcSEcCtD
Oxprenolol—Arthralgia—Doxorubicin—lung cancer	0.000374	0.00191	CcSEcCtD
Oxprenolol—Acebutolol—ABCB1—lung cancer	0.000367	0.241	CrCbGaD
Oxprenolol—Dyspepsia—Methotrexate—lung cancer	0.000364	0.00186	CcSEcCtD
Oxprenolol—Headache—Docetaxel—lung cancer	0.00036	0.00184	CcSEcCtD
Oxprenolol—Fatigue—Methotrexate—lung cancer	0.000357	0.00182	CcSEcCtD
Oxprenolol—Thrombocytopenia—Doxorubicin—lung cancer	0.000351	0.00179	CcSEcCtD
Oxprenolol—Hyperhidrosis—Doxorubicin—lung cancer	0.000346	0.00177	CcSEcCtD
Oxprenolol—Nausea—Docetaxel—lung cancer	0.000341	0.00174	CcSEcCtD
Oxprenolol—Hypotension—Doxorubicin—lung cancer	0.000335	0.00171	CcSEcCtD
Oxprenolol—Abdominal pain—Methotrexate—lung cancer	0.000327	0.00167	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000326	0.00167	CcSEcCtD
Oxprenolol—Insomnia—Doxorubicin—lung cancer	0.000324	0.00165	CcSEcCtD
Oxprenolol—Dyspepsia—Doxorubicin—lung cancer	0.000315	0.00161	CcSEcCtD
Oxprenolol—Metoprolol—ABCB1—lung cancer	0.00031	0.203	CrCbGaD
Oxprenolol—Fatigue—Doxorubicin—lung cancer	0.000309	0.00158	CcSEcCtD
Oxprenolol—Hypersensitivity—Methotrexate—lung cancer	0.000305	0.00156	CcSEcCtD
Oxprenolol—Asthenia—Methotrexate—lung cancer	0.000297	0.00152	CcSEcCtD
Oxprenolol—Propranolol—CYP1A1—lung cancer	0.000294	0.193	CrCbGaD
Oxprenolol—Pruritus—Methotrexate—lung cancer	0.000293	0.00149	CcSEcCtD
Oxprenolol—Abdominal pain—Doxorubicin—lung cancer	0.000283	0.00145	CcSEcCtD
Oxprenolol—Diarrhoea—Methotrexate—lung cancer	0.000283	0.00145	CcSEcCtD
Oxprenolol—Dizziness—Methotrexate—lung cancer	0.000274	0.0014	CcSEcCtD
Oxprenolol—Hypersensitivity—Doxorubicin—lung cancer	0.000264	0.00135	CcSEcCtD
Oxprenolol—Headache—Methotrexate—lung cancer	0.000259	0.00132	CcSEcCtD
Oxprenolol—Asthenia—Doxorubicin—lung cancer	0.000257	0.00131	CcSEcCtD
Oxprenolol—Pruritus—Doxorubicin—lung cancer	0.000253	0.00129	CcSEcCtD
Oxprenolol—Nausea—Methotrexate—lung cancer	0.000246	0.00125	CcSEcCtD
Oxprenolol—Diarrhoea—Doxorubicin—lung cancer	0.000245	0.00125	CcSEcCtD
Oxprenolol—Dizziness—Doxorubicin—lung cancer	0.000237	0.00121	CcSEcCtD
Oxprenolol—Headache—Doxorubicin—lung cancer	0.000224	0.00115	CcSEcCtD
Oxprenolol—Nausea—Doxorubicin—lung cancer	0.000213	0.00109	CcSEcCtD
Oxprenolol—Propranolol—ABCB1—lung cancer	0.000156	0.103	CrCbGaD
Oxprenolol—SLC22A2—Metabolism—GCLC—lung cancer	5.81e-05	0.000511	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP2A6—lung cancer	5.81e-05	0.000511	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—CXCL8—lung cancer	5.8e-05	0.00051	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AVP—lung cancer	5.79e-05	0.000509	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—VEGFC—lung cancer	5.75e-05	0.000505	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CNDP2—lung cancer	5.69e-05	0.0005	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTM2—lung cancer	5.69e-05	0.0005	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—VEGFC—lung cancer	5.62e-05	0.000494	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MTMR3—lung cancer	5.54e-05	0.000487	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ENO1—lung cancer	5.51e-05	0.000484	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—CREBBP—lung cancer	5.5e-05	0.000484	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADCY1—lung cancer	5.43e-05	0.000477	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PGAM1—lung cancer	5.4e-05	0.000474	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ADCY1—lung cancer	5.31e-05	0.000467	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SMARCA4—lung cancer	5.29e-05	0.000465	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PPP2R1B—lung cancer	5.29e-05	0.000465	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PPP2R1B—lung cancer	5.17e-05	0.000455	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SMARCA4—lung cancer	5.17e-05	0.000455	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—ALB—lung cancer	5.15e-05	0.000453	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP2A7—lung cancer	5.15e-05	0.000453	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HSPB1—lung cancer	5.1e-05	0.000449	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PTHLH—lung cancer	5.05e-05	0.000444	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SDC4—lung cancer	5.04e-05	0.000443	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HSPB1—lung cancer	4.99e-05	0.000439	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP2E1—lung cancer	4.94e-05	0.000434	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PTHLH—lung cancer	4.94e-05	0.000434	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—NQO1—lung cancer	4.88e-05	0.000429	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—HRAS—lung cancer	4.77e-05	0.000419	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ANXA1—lung cancer	4.74e-05	0.000417	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—RAF1—lung cancer	4.66e-05	0.000409	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ANXA1—lung cancer	4.64e-05	0.000408	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FLT1—lung cancer	4.59e-05	0.000404	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTA3—lung cancer	4.59e-05	0.000403	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—RRM1—lung cancer	4.59e-05	0.000403	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CG—lung cancer	4.55e-05	0.0004	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NOTCH3—lung cancer	4.5e-05	0.000395	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APP—lung cancer	4.5e-05	0.000395	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FLT1—lung cancer	4.49e-05	0.000395	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FGF9—lung cancer	4.46e-05	0.000392	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CG—lung cancer	4.45e-05	0.000391	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—STK11—lung cancer	4.4e-05	0.000387	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NOTCH3—lung cancer	4.4e-05	0.000387	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APP—lung cancer	4.4e-05	0.000387	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FGF9—lung cancer	4.36e-05	0.000384	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—POMC—lung cancer	4.33e-05	0.000381	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—B4GALT5—lung cancer	4.31e-05	0.000379	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—JUNB—lung cancer	4.26e-05	0.000374	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—POMC—lung cancer	4.24e-05	0.000373	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTA4—lung cancer	4.2e-05	0.000369	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—JUNB—lung cancer	4.17e-05	0.000366	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CG—lung cancer	4.13e-05	0.000363	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTA2—lung cancer	4.09e-05	0.000359	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GSTP1—lung cancer	4.07e-05	0.000358	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CG—lung cancer	4.04e-05	0.000355	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CD—lung cancer	4e-05	0.000352	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CAT—lung cancer	3.96e-05	0.000348	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTA1—lung cancer	3.94e-05	0.000347	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—POMC—lung cancer	3.93e-05	0.000346	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CD—lung cancer	3.91e-05	0.000344	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCC3—lung cancer	3.9e-05	0.000343	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—STK11—lung cancer	3.87e-05	0.00034	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ABCB1—lung cancer	3.85e-05	0.000339	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—POMC—lung cancer	3.85e-05	0.000338	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL6R—lung cancer	3.84e-05	0.000337	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—TYMS—lung cancer	3.79e-05	0.000333	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—STK11—lung cancer	3.78e-05	0.000333	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AKR1C1—lung cancer	3.78e-05	0.000332	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL6R—lung cancer	3.75e-05	0.00033	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GSTM1—lung cancer	3.74e-05	0.000329	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FOXO3—lung cancer	3.73e-05	0.000328	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—UGT1A1—lung cancer	3.67e-05	0.000322	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—MAP2K1—lung cancer	3.66e-05	0.000322	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FOXO3—lung cancer	3.65e-05	0.000321	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CD—lung cancer	3.63e-05	0.000319	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—MAP2K1—lung cancer	3.58e-05	0.000315	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CD—lung cancer	3.55e-05	0.000313	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP1A1—lung cancer	3.55e-05	0.000312	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GNG11—lung cancer	3.54e-05	0.000311	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ERCC2—lung cancer	3.52e-05	0.000309	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AVP—lung cancer	3.5e-05	0.000307	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CB—lung cancer	3.49e-05	0.000307	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AVP—lung cancer	3.42e-05	0.000301	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CB—lung cancer	3.41e-05	0.0003	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALDOA—lung cancer	3.37e-05	0.000296	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IGF1R—lung cancer	3.37e-05	0.000296	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—CXCL8—lung cancer	3.35e-05	0.000295	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HES1—lung cancer	3.31e-05	0.000291	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IGF1R—lung cancer	3.29e-05	0.00029	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—CXCL8—lung cancer	3.28e-05	0.000288	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NCOA3—lung cancer	3.27e-05	0.000287	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—RAF1—lung cancer	3.24e-05	0.000285	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HES1—lung cancer	3.24e-05	0.000284	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—IL2—lung cancer	3.2e-05	0.000282	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ADCY1—lung cancer	3.18e-05	0.00028	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCG2—lung cancer	3.18e-05	0.00028	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—RAF1—lung cancer	3.17e-05	0.000279	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CB—lung cancer	3.17e-05	0.000278	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—IL2—lung cancer	3.13e-05	0.000275	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ENO2—lung cancer	3.12e-05	0.000274	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HPGDS—lung cancer	3.12e-05	0.000274	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPP2R1B—lung cancer	3.1e-05	0.000272	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CB—lung cancer	3.1e-05	0.000272	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOA1—lung cancer	3.04e-05	0.000268	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CXCL8—lung cancer	3.04e-05	0.000268	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTT1—lung cancer	3.02e-05	0.000266	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ERBB3—lung cancer	3.02e-05	0.000266	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP2A6—lung cancer	2.99e-05	0.000263	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GCLC—lung cancer	2.99e-05	0.000263	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CXCL8—lung cancer	2.98e-05	0.000262	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ERBB3—lung cancer	2.96e-05	0.00026	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL2—lung cancer	2.91e-05	0.000256	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TERT—lung cancer	2.9e-05	0.000255	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL2—lung cancer	2.85e-05	0.00025	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TERT—lung cancer	2.83e-05	0.000249	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ENO1—lung cancer	2.83e-05	0.000249	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FGFR1—lung cancer	2.81e-05	0.000247	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CG—lung cancer	2.78e-05	0.000244	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HIF1A—lung cancer	2.77e-05	0.000244	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FGFR1—lung cancer	2.75e-05	0.000242	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HIF1A—lung cancer	2.71e-05	0.000238	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOA1—lung cancer	2.67e-05	0.000235	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KDR—lung cancer	2.65e-05	0.000233	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—POMC—lung cancer	2.65e-05	0.000233	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOA1—lung cancer	2.62e-05	0.00023	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KDR—lung cancer	2.59e-05	0.000228	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CREBBP—lung cancer	2.58e-05	0.000227	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP2E1—lung cancer	2.54e-05	0.000223	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NQO1—lung cancer	2.51e-05	0.000221	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CD—lung cancer	2.44e-05	0.000215	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APC—lung cancer	2.44e-05	0.000215	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CG—lung cancer	2.44e-05	0.000215	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KIT—lung cancer	2.44e-05	0.000215	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—NRAS—lung cancer	2.44e-05	0.000215	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EGF—lung cancer	2.41e-05	0.000212	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ALB—lung cancer	2.41e-05	0.000212	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APC—lung cancer	2.39e-05	0.00021	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CG—lung cancer	2.39e-05	0.00021	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KIT—lung cancer	2.39e-05	0.00021	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—NRAS—lung cancer	2.39e-05	0.00021	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EGF—lung cancer	2.36e-05	0.000208	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—MAPK3—lung cancer	2.34e-05	0.000206	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—POMC—lung cancer	2.32e-05	0.000204	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—BRAF—lung cancer	2.3e-05	0.000202	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—MAPK3—lung cancer	2.29e-05	0.000201	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—POMC—lung cancer	2.27e-05	0.0002	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL6R—lung cancer	2.27e-05	0.000199	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—STK11—lung cancer	2.27e-05	0.000199	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CREBBP—lung cancer	2.26e-05	0.000199	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—BRAF—lung cancer	2.25e-05	0.000197	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—EGFR—lung cancer	2.22e-05	0.000196	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL6R—lung cancer	2.22e-05	0.000195	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CREBBP—lung cancer	2.21e-05	0.000195	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—EGFR—lung cancer	2.18e-05	0.000191	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAP2K1—lung cancer	2.16e-05	0.00019	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CD—lung cancer	2.15e-05	0.000189	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CB—lung cancer	2.13e-05	0.000187	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CA—lung cancer	2.13e-05	0.000187	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAP2K1—lung cancer	2.11e-05	0.000186	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PTGS2—lung cancer	2.11e-05	0.000185	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—KRAS—lung cancer	2.1e-05	0.000185	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CD—lung cancer	2.1e-05	0.000185	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTP1—lung cancer	2.1e-05	0.000184	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CA—lung cancer	2.08e-05	0.000183	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—KRAS—lung cancer	2.06e-05	0.000181	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CAT—lung cancer	2.04e-05	0.000179	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCB1—lung cancer	1.98e-05	0.000174	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TYMS—lung cancer	1.95e-05	0.000171	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CA—lung cancer	1.93e-05	0.00017	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTM1—lung cancer	1.93e-05	0.000169	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MDM2—lung cancer	1.92e-05	0.000169	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RAF1—lung cancer	1.92e-05	0.000168	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ERBB2—lung cancer	1.9e-05	0.000167	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CA—lung cancer	1.89e-05	0.000166	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MDM2—lung cancer	1.88e-05	0.000165	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RAF1—lung cancer	1.87e-05	0.000165	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MTOR—lung cancer	1.87e-05	0.000164	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CB—lung cancer	1.87e-05	0.000164	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ERBB2—lung cancer	1.85e-05	0.000163	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PTEN—lung cancer	1.84e-05	0.000162	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CB—lung cancer	1.83e-05	0.000161	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MTOR—lung cancer	1.83e-05	0.000161	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP1A1—lung cancer	1.83e-05	0.000161	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ERCC2—lung cancer	1.81e-05	0.000159	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CXCL8—lung cancer	1.8e-05	0.000158	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HRAS—lung cancer	1.79e-05	0.000157	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CXCL8—lung cancer	1.76e-05	0.000155	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—EP300—lung cancer	1.75e-05	0.000154	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HRAS—lung cancer	1.75e-05	0.000154	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AKT1—lung cancer	1.74e-05	0.000153	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CASP3—lung cancer	1.72e-05	0.000151	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL2—lung cancer	1.72e-05	0.000151	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL6—lung cancer	1.71e-05	0.00015	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AKT1—lung cancer	1.7e-05	0.000149	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CASP3—lung cancer	1.68e-05	0.000148	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL2—lung cancer	1.68e-05	0.000148	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCND1—lung cancer	1.68e-05	0.000147	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL6—lung cancer	1.67e-05	0.000147	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—JUN—lung cancer	1.67e-05	0.000147	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCND1—lung cancer	1.64e-05	0.000144	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—JUN—lung cancer	1.64e-05	0.000144	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MMP9—lung cancer	1.63e-05	0.000143	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CDKN1A—lung cancer	1.62e-05	0.000142	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PTEN—lung cancer	1.62e-05	0.000142	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MMP9—lung cancer	1.59e-05	0.00014	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CDKN1A—lung cancer	1.59e-05	0.000139	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PTEN—lung cancer	1.58e-05	0.000139	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AKT1—lung cancer	1.58e-05	0.000139	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOA1—lung cancer	1.57e-05	0.000138	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AKT1—lung cancer	1.54e-05	0.000136	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EP300—lung cancer	1.54e-05	0.000136	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EP300—lung cancer	1.51e-05	0.000133	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SRC—lung cancer	1.5e-05	0.000132	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SRC—lung cancer	1.47e-05	0.000129	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—VEGFA—lung cancer	1.46e-05	0.000128	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—STAT3—lung cancer	1.45e-05	0.000127	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NRAS—lung cancer	1.44e-05	0.000127	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CG—lung cancer	1.43e-05	0.000126	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—VEGFA—lung cancer	1.43e-05	0.000126	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—STAT3—lung cancer	1.41e-05	0.000124	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NRAS—lung cancer	1.41e-05	0.000124	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAPK3—lung cancer	1.38e-05	0.000121	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—POMC—lung cancer	1.36e-05	0.00012	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAPK3—lung cancer	1.35e-05	0.000119	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MYC—lung cancer	1.34e-05	0.000118	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CREBBP—lung cancer	1.33e-05	0.000117	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MYC—lung cancer	1.31e-05	0.000116	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EGFR—lung cancer	1.31e-05	0.000116	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CA—lung cancer	1.3e-05	0.000114	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EGFR—lung cancer	1.29e-05	0.000113	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CD—lung cancer	1.26e-05	0.000111	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KRAS—lung cancer	1.24e-05	0.000109	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALB—lung cancer	1.24e-05	0.000109	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KRAS—lung cancer	1.21e-05	0.000107	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CA—lung cancer	1.14e-05	0.0001	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CA—lung cancer	1.12e-05	9.81e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TP53—lung cancer	1.1e-05	9.7e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CB—lung cancer	1.1e-05	9.64e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PTGS2—lung cancer	1.09e-05	9.55e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TP53—lung cancer	1.08e-05	9.49e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AKT1—lung cancer	1.06e-05	9.32e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HRAS—lung cancer	1.06e-05	9.28e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HRAS—lung cancer	1.03e-05	9.08e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL6—lung cancer	1.01e-05	8.88e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL6—lung cancer	9.88e-06	8.69e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PTEN—lung cancer	9.47e-06	8.33e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKT1—lung cancer	9.32e-06	8.19e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKT1—lung cancer	9.11e-06	8.01e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—EP300—lung cancer	9.03e-06	7.94e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CA—lung cancer	6.68e-06	5.87e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AKT1—lung cancer	5.46e-06	4.8e-05	CbGpPWpGaD
